Lilly to acquire Centessa Pharma to advance treatments for sleep-wake disorders in deal worth up to $7.8 Billion
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
-
-
Artificial Intelligence | Biotechnology | Diagnostics | Infectious Disease | Medical Device | Neurology | Pharmaceutical | Therapeutics
China biotech deals hit record as innovative drugs draw interest of multinationals
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
-
An analysis of 2.2 million people reveals shared and substance-specific genetic pathways for addiction risk
On Mar. 20, 2026, researchers of a Rutgers Health–led study led by Holly Poore, a faculty instructor of psychiatry…
-
Agriculture | Artificial Intelligence | Biotechnology | Diagnostics | Environmental | FDA | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine | Veterinary | Women's Health
National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’
On Mar. 19, 2026, a nationwide STAT survey of federally funded researchers reveals that, a year after Donald…
-
Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
On Mar. 18, 2026, Nia Therapeutics announced that the U.S. Food and Drug Administration has granted Breakthrough Device…
-
Biotechnology | Cardiology | Diagnostics | FDA | Neurology | NIH | Rare Disease | Therapeutics | Women's Health
NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
-
China approves world’s first brain implant for commercialisation
On Mar. 14, 2026, China has approved its first brain implant designed to help people with paralysis regain…
-
Stanley Family Foundation renews commitment to accelerate psychiatric research at Broad Institute
On Mar. 12, 2026, the Stanley Family Foundation renewed its commitment to psychiatric research at the Broad Institute,…
-
Biotechnology | Diagnostics | Medical Device | Medicine | Neurology | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Mass General Brigham Receives Transformative $50 Million Gift to Shape Future of Cancer Research
On Mar. 12, 2026, Mass General Brigham (MGB) announced it has received a $50 million gift that will…
-
USC study reveals differences in early Alzheimer’s brain markers across diverse populations
On Mar. 12, 2026, a team of researchers at the University of Southern California Mark and Mary Stevens…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
New Study Exposes Hidden Alzheimer’s “Hot Spots” in Rural Maryland and What They Reveal About America’s Growing Healthcare Divide
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
-
Sumitomo Receives Approval for world’s first iPS cell‑derived regenerative medicine in Japan
On Mar. 6, 2026, Sumitomo Pharma announce it has obtained conditional and time‑limited approval in Japan for the…
-
Merck and Mayo Clinic Announce R&D Collaboration Supporting AI-Enabled Drug Discovery and Precision Medicine
On Feb. 18, 2026, Merck, known as MSD outside of the U.S. and Canada, and Mayo Clinic, the…
-
Chemistry-Powered “Breathing” Membrane Opens and Closes Tiny Pores on Its Own
On Feb. 18, 2026, researchers at SANKEN, University of Osaka announced using a nanoreactor to produce pores that…
-
Cardiology | Diagnostics | Disease | Energy | Environmental | EPA | Genomics | Neurology | Oncology | U.S. Congress | Women's Health
EPA revokes scientific finding that underpinned US fight against climate change
On Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | Neurology | NIH | U.S. Congress | USDA | Veterinary
OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuary
On Feb. 9, 2026, the Oregon Health and Science University (OHSU) board of directors unanimously passed a resolution…
-
New stem cell treatment may offer hope for Parkinson’s disease
On Feb. 4, 2026, Keck Medicine of the University of Southern California (USC) announced it is conducting an early phase clinical…
-
Banning lead in gas worked – The proof is in our hair
On Feb. 2, 2026, University of Utah scientists reports an analysis of hair samples shows precipitous reductions in…
-
Early signs of Parkinson’s can be identified in the blood
On Jan. 29, 2026, a team led by researchers at Chalmers University of Technology and Oslo University Hospital,…
-
Menopause linked to loss of grey matter in the brain, poorer mental health and sleep disturbance
On Jan. 27, 2026, a University of Cambridge study shows menopause is linked to reductions in grey matter…
-
New atlas could help researchers studying neurological disease
On Jan. 22, 2026, researchers backed by a Knight Initiative for Brain Resilience Catalyst Momentum Award have laid out…
-
Rice University establishes Global Brain Economy Initiative, aligned with new report on brain health and AI
On Jan. 21, 2026, Rice University launched the Global Brain Economy Initiative (GBEI) during the annual meeting of…
-
Researchers pinpoint biomarkers for schizophrenia
On Jan. 20, 2026, researchers announced they have identified two biomarkers — verbal learning and identifying other peoples’…
-
Researchers discover potential new target to treat Parkinson’s disease
On Jan. 15, 2026, a team of Case Western Reserve University researchers announced they have discovered a particular…
-
Lyme Disease Health Care Costs Exceed $1 billion Annually
On Jan. 14, 2026, a new study published in JAMA Network suggest that health care costs associated with…
-
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases for $1.2 billion
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
-
Widely used pesticide linked to more than doubled Parkinson’s risk
On Jan. 7, 2026, a study from UCLA Health found that long-term residential exposure to the pesticide chlorpyrifos…
-
How common is Alzheimer’s? Blood-test study holds surprises
On Dec. 17, 2025, A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show…
